Background: The use of coronary computed tomography angiography (CCTA) for noninvasive anatomic detection of coronary artery disease is increasing. Recently, fractional flow reserve (FFR) assessment using routinely acquired CCTA datasets (FFRCT) has been developed. However, there are no reports about changes in coronary atherosclerosis, composition, and FFRCT in patients with type 2 diabetes. Methods: This prospective, multicenter, observational trial evaluated changes in coronary atherosclerosis after alogliptin therapy in patients with type 2 diabetes. Fifty-one patients with type 2 diabetes who underwent CCTA examination and having intermediate coronary artery stenosis were treated with 25 mg of alogliptin. After 48 weeks, CCTA examinati...
It is well known that diabetic patients have a high risk of cardiovascular events, and although ther...
Background: Coronary inflammation causes significantly increased risk of cardiovascular disease (CVD...
ObjectivesThis study aimed to determine the rate and extent of plaque progression (PP), changes in p...
Background: To investigate the impact of diabetes on coronary artery total plaque volume (TPV) and a...
Background: Data on the impact of glycemic status on coronary plaque progression have been limited. ...
OBJECTIVES: This study evaluated the association between atherosclerotic plaque characteristics (APC...
ObjectivesThis study evaluated the association between atherosclerotic plaque characteristics (APCs)...
BACKGROUND Absence of subclinical atherosclerosis is considered safe to defer statin therapy in g...
OBJECTIVES: This study aimed to determine the rate and extent of plaque progression (PP), changes in...
OBJECTIVE - It is unclear whether the coronary atherosclerotic plaque burden is similar in patients ...
Background: We hypothesize that in patients with suspected coronary artery disease (CAD), lower valu...
PURPOSE: To determine the relationship between carotid intima-media thickness (IMT), coronary artery...
Background and aimsWe aimed at investigating whether diabetes is associated with progression in coro...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objectives: This study evaluates the relationship between atherosclerotic plaque characteristics ...
It is well known that diabetic patients have a high risk of cardiovascular events, and although ther...
Background: Coronary inflammation causes significantly increased risk of cardiovascular disease (CVD...
ObjectivesThis study aimed to determine the rate and extent of plaque progression (PP), changes in p...
Background: To investigate the impact of diabetes on coronary artery total plaque volume (TPV) and a...
Background: Data on the impact of glycemic status on coronary plaque progression have been limited. ...
OBJECTIVES: This study evaluated the association between atherosclerotic plaque characteristics (APC...
ObjectivesThis study evaluated the association between atherosclerotic plaque characteristics (APCs)...
BACKGROUND Absence of subclinical atherosclerosis is considered safe to defer statin therapy in g...
OBJECTIVES: This study aimed to determine the rate and extent of plaque progression (PP), changes in...
OBJECTIVE - It is unclear whether the coronary atherosclerotic plaque burden is similar in patients ...
Background: We hypothesize that in patients with suspected coronary artery disease (CAD), lower valu...
PURPOSE: To determine the relationship between carotid intima-media thickness (IMT), coronary artery...
Background and aimsWe aimed at investigating whether diabetes is associated with progression in coro...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objectives: This study evaluates the relationship between atherosclerotic plaque characteristics ...
It is well known that diabetic patients have a high risk of cardiovascular events, and although ther...
Background: Coronary inflammation causes significantly increased risk of cardiovascular disease (CVD...
ObjectivesThis study aimed to determine the rate and extent of plaque progression (PP), changes in p...